While the complete response letter derails a near-term clearance, one analyst described the rejection as more of “a speed ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...

From Kai Schreiber to Romy Mars, meet the new class of It kids taking over.

When a nonprofit meets the right expert at the right time, amazing things can happen. That’s exactly what unfolded when Bloom featured the powerful story of a partnership ...

Metagenomi Inc. (NASDAQ: MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...

Ambitious projects aim to put dire wolves, woolly mammoths and passenger pigeons back into our ecosystems. But with so many ...

Medically reviewed by Jeffrey S. Lander, MD ATTR-CM is an acronym for the medical condition called transthyretin amyloid cardiomyopathy. There are two causes of ATTR-CM, an inherited gene mutation and ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.

Zebrafish can regenerate sensory hair cells that humans permanently lose, like those in the inner ear linked to hearing and balance. New research reveals two specific genes that control how different ...

The firm said the agency cited chemistry, manufacturing, and controls issues in its complete response letter, but had no concerns about product quality.

The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...